Indeed, the clinical literature exhibits heterogeneity in design, dosing, duration, and outcome measures, frequent reliance on parent reported scales without uniform blinding, and underpowered samples that hinder strong inference and guideline development (Doherty et al., 2022
Tenenbein M (2004)
Descripcin del producto FRMULA AVANZADA CON NAC Y GLUTATIN LIPOSOMAL: Nuestra frmula combina N-Acetil-Cistena (NAC) y Glutatin en su forma liposomal, dos compuestos presentes de forma natural en el organismo
A compound with genuinely novel mechanism data from multiple animal species, demonstrated efficacy, and a clear molecular target essentially disappeared from the clinical pipeline without public explanation
If the supplement is destroyed in the stomach, you are unlikely to see the benefits you are looking for
The translational opportunity lies in reframing clinical problems into mechanistically interpretable categories